Biotech · Private company
OxThera
Track this companyFree. Adds OxThera to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Oxabact OC5 - Oxalobacter formigenes HC-1Phase 3 · Primary HyperoxaluriaClinicalTrials.gov · fetched Nov 12, 2026
- Oxabact OC5 - Oxalobacter formigenes Strain HC-1Phase 3 · Hyperoxaluria, PrimaryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary HyperoxaluriaPHASE3 · TERMINATED · started Mar 14, 2019ClinicalTrials.gov NCT03938272 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary HyperoxaluriaPHASE3 · COMPLETED · started Jan 9, 2018ClinicalTrials.gov NCT03116685 · fetched Nov 12, 2026